RX-0201

N/A

Report date: 2023/03/31 17:22:51
NME

Base Information

Drug NameRX-0201
Drug Alias NameArchexinRX-0201WGI-0201HC0201
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitors
TargetsSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRexahn Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZhejiang Haichang Biopharmaceuticals Co LtdRexahn Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A